Persistent microalbuminuria in adolescents with type I (insulin-dependent) diabetes mellitus is associated to early rather than late puberty. Results of a prospective longitudinal study

Janner, M.; Knill, S. E.; Diem, P.; Zuppinger, K. A.; Mullis, P. E. (1994). Persistent microalbuminuria in adolescents with type I (insulin-dependent) diabetes mellitus is associated to early rather than late puberty. Results of a prospective longitudinal study. European journal of pediatrics, 153(6), pp. 403-408. Berlin: Springer 10.1007/s004310050162

[img]
Preview
Text
Janner1994_Article_PersistentMicroalbuminuriaInAd.pdf - Published Version
Available under License Publisher holds Copyright.

Download (597kB) | Preview

Microalbuminuria is generally accepted to be highly predictive of overt diabetic nephropathy which is the leading cause of end-stage renal failure and, consequently, of death in patients with type 1 (insulin-dependent) diabetes mellitus (IDDM). Its early identification and therapy are exceedingly important. We studied prospectively the occurrence of microalbuminuria (MA) in relation to puberty and its pubertal stages in 164 children and adolescent patients (83 girls and 81 boys) with IDDM. Analysing 100 healthy subjects, normal values for albumin excretion (range: 0-10.1 micrograms/min/1.73 m2) according to sex and the different pubertal stages were defined. No significant difference between the groups were noted and, therefore, 20 micrograms/min per 1.73 m2 (3 SD above the mean) was generally defined as cutoff for MA. Of the patients with IDDM studied, 20% (20 females and 12 males) developed persistent MA (22.1-448.2 micrograms/min/1.73 m2) during the study period of 8 years. The first manifestation of persistent MA was in 69% (13 females and 9 males) during stages of early and midpuberty; and in 28% (6 females and 3 males) at a late pubertal stage or at the end of puberty. The only child who developed MA before the onset of puberty (range: 23.5-157.4 micrograms/min/1.73 m2) was found to have dystopic kidney. Therefore, all patients with IDDM should be screened for MA regardless of diabetes duration, sex and level of diabetes control beginning at the very first stage of puberty and neither earlier nor after puberty as suggested by the American Diabetes Association.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > Unit Childrens Hospital > Forschungsgruppe Endokrinologie / Diabetologie / Metabolik (Pädiatrie)
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Endocrinology, Diabetology and Clinical Nutrition

UniBE Contributor:

Janner, Marco, Diem, Peter

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0340-6199

ISBN:

8088293

Publisher:

Springer

Language:

English

Submitter:

Anette van Dorland

Date Deposited:

04 Oct 2013 14:56

Last Modified:

05 Dec 2022 14:17

Publisher DOI:

10.1007/s004310050162

PubMed ID:

8088293

Web of Science ID:

A1994NP10500003

BORIS DOI:

10.48350/23873

URI:

https://boris.unibe.ch/id/eprint/23873 (FactScience: 44887)

Actions (login required)

Edit item Edit item
Provide Feedback